Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This expanded access program provides investigational levacetylleucine to patients with Ataxia-Telangiectasia who are not eligible for clinical trials and have no satisfactory alternative therapies.
Epistemonikos ID: 387e5f4b7da72c874a57780796bc87cb3755a039
First added on: Feb 03, 2026